RN

Roger Nitsch

UZ Universitat Zurich: 13 patents #3 of 394Top 1%
UZ Universität Zürich: 11 patents #1 of 243Top 1%
BG Biogen International Neuroscience Gmbh: 9 patents #2 of 19Top 15%
MIT: 4 patents #1,242 of 9,367Top 15%
NA Neurimmune Holding Ag: 3 patents #5 of 19Top 30%
NU New York University: 2 patents #380 of 1,640Top 25%
DA Delenex Therapeutics Ag: 2 patents #2 of 11Top 20%
BO BOE: 1 patents #7,844 of 12,373Top 65%
📍 Zumikon, MA: #1 of 1 inventorsTop 100%
Overall (All Time): #109,439 of 4,157,543Top 3%
32
Patents All Time

Issued Patents All Time

Showing 1–25 of 32 patents

Patent #TitleCo-InventorsDate
12201619 Compounds and methods for use in the treatment of microglia-mediated disorders Abraham Fisher, Stefan GRATHWOHL 2025-01-21
11352441 Human anti-SOD1 antibodies Fabio Montrasio, Maria Grazia Barenco Montrasio, Jan Grimm, Christoph Hock, Tobias Welt +2 more 2022-06-07
11091540 TDP-43 specific binding molecules Christoph Hock, Maria Grazia Barenco Montrasio, Fabio Montrasio, Jan Grimm, Jean-Luc Baeriswyl +3 more 2021-08-17
10874725 Method of providing patient specific immune response in amyloidoses and protein aggregation disorders Karsten Henco, Jan Grimm, Anja Zeller, Marcel Maier 2020-12-29
10703808 Human anti-alpha-synuclein antibodies Andreas Weihofen, Jan Grimm, Christoph Hock 2020-07-07
10344097 Human anti-SOD1 antibodies Fabio Montrasio, Maria Grazia Barenco Montrasio, Jan Grimm, Christoph Hock, Tobias Welt +2 more 2019-07-09
10301381 Anti-alpha synuclein binding molecules Andreas Weihofen, Jan Grimm, Christoph Hock, Lihe Su, Paul H. Weinreb 2019-05-28
10259866 TDP-43 specific binding molecules Christoph Hock, Maria Grazia Barenco Montrasio, Fabio Montrasio, Jan Grimm, Jean-Luc Baeriswyl +3 more 2019-04-16
10202445 Method of providing disease-specific binding molecules and targets Christoph Hock, Christoph Esslinger, Marlen Knobloch, Kathrin Tissot, Jan Grimm 2019-02-12
10131708 Methods of treating Alzheimer's disease Christoph Hock, Christoph Esslinger, Marlen Knobloch, Kathrin Tissot, Jan Grimm 2018-11-20
9975947 Anti-alpha synuclein binding molecules Andreas Weihofen, Jan Grimm, Christoph Hock, Lihe Su, Paul H. Weinreb 2018-05-22
9896504 Human anti-alpha-synuclein antibodies Andreas Weihofen, Jan Grimm, Christoph Hock 2018-02-20
9828420 Method of providing disease-specific binding molecules and targets Christoph Hock, Christoph Esslinger, Marlen Knobloch, Kathrin Tissot, Jan Grimm 2017-11-28
9670272 Method of providing disease-specific binding molecules and targets Christoph Hock, Christoph Esslinger, Marlen Knobloch, Kathrin Tissot, Jan Grimm 2017-06-06
9605059 Human anti-tau antibodies Feng Chen, Jan Grimm, Jean-Luc Baeriswyl, Christoph Hock 2017-03-28
9587014 TDP-43 specific binding molecules Christoph Hock, Maria Grazia Barenco Montrasio, Fabio Montrasio, Jan Grimm, Jean-Luc Baeriswyl +3 more 2017-03-07
9580493 Anti-α synuclein binding molecules Andreas Weihofen, Jan Grimm, Christoph Hock, Lihe Su, Paul H. Weinreb 2017-02-28
9370531 Method of providing patient specific immune response in amyloidoses and protein aggregation disorders Karsten Henco, Jan Grimm, Anja Zeller, Marcel Maier 2016-06-21
9283271 Human anti-SOD1 antibodies Fabio Montrasio, Maria Grazia Barenco Montrasio, Jan Grimm, Christoph Hock, Marcel Maier 2016-03-15
9273126 Humanized antibodies against the beta-amyloid peptide Stefan Ewert, Adrian Auf Der Maur, Susann Cattepoel 2016-03-01
8940276 Human anti-alpha-synuclein antibodies Andreas Weihofen, Jan Grimm, Christoph Hock 2015-01-27
8940272 Human anti-tau antibodies Feng Chen, Jan Grimm, Jean-Luc Baeriswyl, Christoph Hock 2015-01-27
8906367 Method of providing disease-specific binding molecules and targets Christoph Hock, Christoph Esslinger, Marlen Knobloch, Kathrin Tissot, Jan Grimm 2014-12-09
8519106 Monoclonal human tumor-specific antibody Christoph Esslinger, Sandra Künzle, Irene Abela, Alfred Zippelius, Dirk Jager +3 more 2013-08-27
8323647 Humanized antibodies against the β-amyloid peptide Stefan Ewert, Adrian Auf Der Maur, Susann Cattepoel 2012-12-04